Amyloidosis: open trials in Greece

8 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT07224672
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Trial Treatment · Phase 2 · GlaxoSmithKline
General Hospital of Athens - Alexandra, Athens · "Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-11-03
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Hippokration Hospital, Athens · Alexandra Hospital, Athens · General Hospital Venizeleio, Heraklion · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-10-20
NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
General Hospital of Athens - Alexandra, Athens · University General Hospital of Heraklion, Heraklion
Registry updated 2026-10-08
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Alexandra Hospital, Athens
Registry updated 2026-08-18
NCT07116473
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Hippokration Hospital, Athens · General Hospital of Athens - Alexandra, Athens
Registry updated 2026-08-11
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Hippokration Hospital, Athens · Alexandra Hospital, Athens
Registry updated 2026-08-04
NCT06158854
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Trial Treatment · Phase 1/2 · AbbVie
Alexandra Hospital, Athens
Registry updated 2026-05-13
NCT05667493
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.
General Hospital of Athens - Alexandra, Athens
Registry updated 2026-04-17

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error